Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene
Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export.
Martin S, Smolders S, Van den Haute C, Heeman B, van Veen S, Crosiers D, Beletchi I, Verstraeten A, Gossye H, Gelders G, Pals P, Hamouda NN, Engelborghs S, Martin JJ, Eggermont J, De Deyn PP, Cras P, Baekelandt V, Vangheluwe P, Van Broeckhoven C
Acta Neuropathol. 2020 Jun;139(6):1001-1024. doi: 10.1007/s00401-020-02145-7. Epub 2020 Mar 14.
PubMed Article

Plasmids from Article

ID Plasmid Purpose
171770pLenti HsATP10B WTtransfer plasmid for lentiviral vector production expressing Hs ATP10B WT
171789pLenti TMEM30Atransfer plasmid for lentiviral vector production expressing TMEM30A
171790miR2 HsATP10Btransfer plasmid for lentiviral vector production with miR for Hs ATP10B
171791miR5 MmATP10Btransfer plasmid for lentiviral vector production with miR for Mm ATP10B
171823pLenti HsATP10B D433Ntransfer plasmid for lentiviral vector production expressing Hs ATP10B D433N
171824miR3 HsATP10Btransfer plasmid for lentiviral vector production with miR for Hs ATP10B
171825miR7 MmATP10Btransfer plasmid for lentiviral vector production with miR for Mm ATP10B

Antibodies from Article